Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by Attenuating Oxidative Stress and Neuroinflammation
Qinglu Yang,Ruitong Li,Yigen Hong,Hongsheng Liu,Chuyao Jian,Shaofeng Zhao
DOI: https://doi.org/10.2147/ijn.s487628
IF: 7.033
2024-11-10
International Journal of Nanomedicine
Abstract:Qinglu Yang, 1, &ast Ruitong Li, 2, &ast Yigen Hong, 1 Hongsheng Liu, 3 Chuyao Jian, 1 Shaofeng Zhao 1 1 Department of Rehabilitation Medicine, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, People's Republic of China; 2 Department of Psychology and Human Development, IOE, UCL's Faculty of Education and Society, University College London, London, WC1H 0AL, UK; 3 Guangdong Huayi Biomedical Science and Technology Center, Guangzhou, Guangdong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chuyao Jian; Shaofeng Zhao, Email ; Background: Ischemic stroke is a medical emergency for which effective treatment remains inadequate. Curcumin (Cur) is a natural polyphenolic compound that is regarded as a potent neuroprotective agent. Compared to synthetic pharmaceuticals, Cur possesses minimal side effects and exhibits multiple mechanisms of action, offering significant advantages in the treatment of ischemic stroke. However, drawbacks such as poor water solubility and transmembrane permeability limit the efficacy of Cur. In recent years, nano-delivery systems have attracted great interest in the field of stroke therapy as an effective method to improve drug solubility and cross the blood-brain barrier (BBB). Methods: In this study, a novel nanomedicine (Cur@GAR NPs) for ischemic stroke treatment was developed based on Cur-loaded gelatin nanoparticles (Cur@Gel NPs) that were then functionalized and modified with rabies virus glycoprotein (RVG29) to target brain tissue. The stability, antimicrobial properties, antioxidant properties, neuroprotective effects, neuronal cell uptake, and biocompatibility of Cur@GAR NPs were investigated in vitro. The in vivo therapeutic effect of Cur@GAR NPs on ischemic stroke was investigated in a middle cerebral artery occlusion (MCAO) rat model using the Morris water maze test and the open field test, and the potential mechanism of action was further investigated by histological analysis. Results: The resulting Cur@GAR NPs improved the solubility of Cur and exhibited good dispersion. In vitro studies have shown that Cur@GAR NPs exhibit great antimicrobial properties, antioxidant properties and intracellular reactive oxygen species (ROS) protection. Notably, RVG29 significantly enhanced the uptake of Cur@GAR NPs by SH-SY5Y cells. Furthermore, in vivo studies verified the role of Cur@GAR NPs in reducing nerve damage and supporting neurological recovery. In the MCAO rat model, Cur@GAR NPs significantly attenuated neuroinflammation, reduced neuronal apoptosis and restored behavioral functions to a great extent. Conclusion: Together these findings implied that Cur@GAR NPs could provide a novel and promising approach for effective ischemic stroke treatment. Keywords: ischemic stroke, nanomedicine, anti-inflammatory, antioxidant, targeted delivery Graphical Stroke is a severe medical emergency caused by an interruption or blockage of the blood supply to a specific area of the brain. 1 Ischemic stroke is the most common type of stroke and poses a significant risk of mortality and disability. 2–4 When blood flow to the brain is suddenly interrupted, nerve cells are rapidly affected by hypoxia and nutrient deficiency, resulting in ischemic injury. Ischemic injury triggers microglia in the brain to convert to a pro-inflammatory phenotype, producing large amounts of inflammatory mediators. These inflammatory mediators further recruit and activate peripheral immune cells, exacerbating the inflammatory response. In addition, insufficient intracellular oxygen supply during ischemia leads to mitochondrial dysfunction, metabolic disturbances, and energy depletion. When blood flow is reperfused, the sudden increase in oxygen leads to the production of large amounts of reactive oxygen radicals (ROS), resulting in oxidative stress. Neuroinflammation and oxidative stress mutually promote and amplify each other, establishing a vicious cycle that precipitates neuronal injury and death. 5–7 Currently, thrombolysis and neuroprotection are the two main therapeutic options for ischemic stroke intervention. 8 However, there is still no effective treatment for ischemic stroke due to limitations such as a narrow therapeutic window, low success rate of single-agent therapy, systemic toxicity, and BBB impediments to drug delivery. 9–11 As such, it is imperative to develop new therapeutic strategies for treating ischemic stroke. Prior research has demonstrated that numerous active ingredients extracted from traditional herbs exhibit protective effects against i -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology